Iwamoto T, Fujisawa T, Shien T, Araki K, et al. The efficacy of sequential second-line endocrine therapies (ETs) in
postmenopausal estrogen receptor-positive and HER2-negative metastatic breast
cancer patients with lower sensitivity to initial ETs. Breast Cancer 2020 May 11. pii: 10.1007/s12282-020-01095.
PMID: 32394413